Basics Repare Therapeutics Inc. IPO Date: May 2, 2022 Sector: Healthcare Industry: Biotech Market Cap: $80.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.42 | 3.12% Avg Daily Range (30 D): $0.03 | 1.80% Avg Daily Range (90 D): $0.03 | 1.73% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 111 Avg Trade Size (Sh.) (30 D): 263 Avg Trade Size (Sh.) (90 D): 221 Institutional Trades Total Inst.Trades: 55 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.49M Avg Closing Trade (30 D): $2.61M Avg Closing Trade (90 D): $2.61M Avg Closing Volume: 162.82K     News Jun 6, 2025 @ 9:36 AM Companion Diagnostic Markets Report 2025-2029: Dia... Source: Researchandmarkets.Com Jan 20, 2025 @ 3:30 PM CNL’S CNRI-H Program Continues Strong Growt... Source: N/A Jun 6, 2024 @ 1:59 PM Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets ... Source: Zacks Equity Research Feb 20, 2024 @ 3:00 PM Repare Therapeutics Inc. (RPTX) May Report Negativ... Source: Zacks Equity Research Feb 13, 2024 @ 9:45 AM Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Fur... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.39 $-.71 Diluted EPS $-.39 $-.71 Revenue $ $ 5.92M $ M Gross Profit $ $ $ Net Income / Loss $ $ -16.74M $ -30.04M Operating Income / Loss $ $ -17.78M $ -31.19M Cost of Revenue $ $ $ Net Cash Flow $ $ -16.8M $ -.26M PE Ratio